Your session is about to expire
← Back to Search
Virtual Reality for Muscle Spasms
N/A
Waitlist Available
Led By Chantel Barney, PhD
Research Sponsored by Gillette Children's Specialty Healthcare
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must not have
Patients who are fully anesthetized during their medical procedure
Patients with epilepsy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 days
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if using Virtual Reality can reduce pain and anxiety during botulinum toxin injections. VR aims to distract patients by immersing them in a virtual world, making the procedure less uncomfortable. Immersive virtual reality (VR) has shown efficacy in treatment of procedural discomfort in pediatric patients receiving botulinum toxin injections for spasticity.
Who is the study for?
This trial is for patients at Gillette Children's Specialty Healthcare who are getting botulinum toxin injections. It's not for those who will be fully anesthetized, don't speak English, have surgery scheduled during the study, suffer from epilepsy or motion sickness, or have a ventricular shunt.
What is being tested?
The trial tests if using Virtual Reality during painful medical procedures like botulinum toxin injections can reduce pain and anxiety compared to standard care. Participants are randomly chosen to receive VR or standard care while being observed.
What are the potential side effects?
Since this trial involves Virtual Reality, side effects may include discomfort such as dizziness or nausea related to motion sickness but generally should be minimal.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I will be fully asleep during my medical procedure.
Select...
I have epilepsy.
Select...
I will have surgery during the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Pain
Secondary study objectives
A series of visual analogue scales (VAS) to assess pain, anxiety, satisfaction with pain management, and perceived benefits of VR.
Information collected from the medical record (e.g., medication use during procedure).
Pain
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual Reality for distractionExperimental Treatment1 Intervention
The application of VR during the putative painful treatment (botulinum toxin injections) will provide a) active and engaging distraction during the procedure, and will b) block the view and auditory noise related to the procedure.
Group II: Standard of CareActive Control1 Intervention
Patients will receive the standard of care for the putative painful treatment (botulinum toxin injections).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality
2017
Completed Phase 3
~1580
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for muscle spasms, such as Virtual Reality (VR) therapy, repetitive transcranial magnetic stimulation (rTMS), transcutaneous electrical nerve stimulation (TENS), and vibratory stimulation, work by modulating neural activity to reduce muscle hyperactivity. VR therapy uses distraction and sensory immersion to engage the brain and reduce the perception of pain and discomfort. rTMS and TENS apply electromagnetic and electrical stimuli, respectively, to alter neural circuits and decrease spasticity.
Vibratory stimulation leverages mechanical vibrations to influence muscle tone and motor control. These mechanisms are important for muscle spasm patients as they can significantly alleviate pain, improve functional mobility, and enhance overall quality of life.
Vibratory stimulation. Part III. Possible applications of vibration in treatment of motor dysfunctions.Effects of a Virtual Reality-Based Mirror Therapy Program on Improving Sensorimotor Function of Hands in Chronic Stroke Patients: A Randomized Controlled Trial.Comparison of the effect of focused and radial extracorporeal shock waves on spastic equinus in patients with stroke: a randomized controlled trial.
Vibratory stimulation. Part III. Possible applications of vibration in treatment of motor dysfunctions.Effects of a Virtual Reality-Based Mirror Therapy Program on Improving Sensorimotor Function of Hands in Chronic Stroke Patients: A Randomized Controlled Trial.Comparison of the effect of focused and radial extracorporeal shock waves on spastic equinus in patients with stroke: a randomized controlled trial.
Find a Location
Who is running the clinical trial?
Gillette Children's Specialty HealthcareLead Sponsor
30 Previous Clinical Trials
8,022 Total Patients Enrolled
Chantel Barney, PhDPrincipal InvestigatorGillette Children's Specialty Healthcare
1 Previous Clinical Trials
48 Total Patients Enrolled
Chantel Burkitt, PhDPrincipal InvestigatorGillette Children's Specialty Healthcare
1 Previous Clinical Trials
500 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I will be fully asleep during my medical procedure.You have experienced motion sickness in the past.I have epilepsy.You have a device called a ventricular shunt.I will have surgery during the study.You are currently getting botulinum toxin injections at Gillette Children's Specialty Healthcare.
Research Study Groups:
This trial has the following groups:- Group 1: Virtual Reality for distraction
- Group 2: Standard of Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.